JMP Securities reiterated a Market Outperform rating on Sprinklr Inc (NYSE:CXM), with a steady price target of $17.00. The firm's analysts highlighted the company's current performance, which includes ...
JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...
JMP Securities analyst Patrick Walravens maintained a Buy rating on Sprinklr (CXM – Research Report) today and set a price target of $17.00.
In a report released today, David Turkaly from JMP Securities maintained a Buy rating on Haemonetics (HAE – Research Report), with a price ...
JMP Securities raised its stock price target to $1300 on January 21st. They reiterated a Buy rating amid expectation that the company will benefit from increased spending on its Software Asset ...
On Friday, JMP Securities reiterated a Market Perform rating on Old Republic International (NYSE:ORI), following the company's fourth-quarter results that surpassed expectations. The insurance ...
On Friday, JMP Securities provided an update on Property Technology (PropTech) stocks in anticipation of the fourth quarter earnings reports. The firm highlighted that despite the residential real ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results